These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24056375)

  • 1. Hunter syndrome (Mucopolysaccharidosis type II), severe phenotype: long term follow-up on patients undergone to hematopoietic stem cell transplantation.
    Annibali R; Caponi L; Morganti A; Manna M; Gabrielli O; Ficcadenti A
    Minerva Pediatr; 2013 Oct; 65(5):487-96. PubMed ID: 24056375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis type II, Hunter's syndrome.
    Tylki-Szymańska A
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():107-13. PubMed ID: 25345092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years.
    Guffon N; Bertrand Y; Forest I; Fouilhoux A; Froissart R
    J Pediatr; 2009 May; 154(5):733-7. PubMed ID: 19167723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.
    Tanaka A; Okuyama T; Suzuki Y; Sakai N; Takakura H; Sawada T; Tanaka T; Otomo T; Ohashi T; Ishige-Wada M; Yabe H; Ohura T; Suzuki N; Kato K; Adachi S; Kobayashi R; Mugishima H; Kato S
    Mol Genet Metab; 2012 Nov; 107(3):513-20. PubMed ID: 23022072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome).
    Papadia F; Lozupone MS; Gaeta A; Capodiferro D; Lacalendola G
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):253-8. PubMed ID: 21528770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary management of Hunter syndrome.
    Muenzer J; Beck M; Eng CM; Escolar ML; Giugliani R; Guffon NH; Harmatz P; Kamin W; Kampmann C; Koseoglu ST; Link B; Martin RA; Molter DW; Muñoz Rojas MV; Ogilvie JW; Parini R; Ramaswami U; Scarpa M; Schwartz IV; Wood RE; Wraith E
    Pediatrics; 2009 Dec; 124(6):e1228-39. PubMed ID: 19901005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome).
    Peters C; Krivit W
    Bone Marrow Transplant; 2000 May; 25(10):1097-9. PubMed ID: 10828872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in Hunter syndrome (mucopolysaccharidosis type II): two-year follow-up of the first Italian patient and review of the literature.
    Coppa GV; Gabrielli O; Zampini L; Pierani P; Giorgi PL; Jezequel AM; Orlandi F; Miniero R; Busca A; De Luca T
    Pediatr Med Chir; 1995; 17(3):227-35. PubMed ID: 7567644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.
    Tanjuakio J; Suzuki Y; Patel P; Yasuda E; Kubaski F; Tanaka A; Yabe H; Mason RW; Montaño AM; Orii KE; Orii KO; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2015 Feb; 114(2):161-9. PubMed ID: 25468646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation.
    Araya K; Sakai N; Mohri I; Kagitani-Shimono K; Okinaga T; Hashii Y; Ohta H; Nakamichi I; Aozasa K; Taniike M; Ozono K
    Mol Genet Metab; 2009 Nov; 98(3):255-63. PubMed ID: 19556155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia.
    Mullen CA; Thompson JN; Richard LA; Chan KW
    Bone Marrow Transplant; 2000 May; 25(10):1093-7. PubMed ID: 10828871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical practice guideline for the management of Hunter syndrome. Hunter España working group].
    Guillén-Navarro E; Blasco AJ; Gutierrez-Solana LG; Couce ML; Cancho-Candela R; Lázaro P;
    Med Clin (Barc); 2013 Nov; 141(10):453.e1-13. PubMed ID: 24060500
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.
    Kubaski F; Yabe H; Suzuki Y; Seto T; Hamazaki T; Mason RW; Xie L; Onsten TGH; Leistner-Segal S; Giugliani R; Dũng VC; Ngoc CTB; Yamaguchi S; Montaño AM; Orii KE; Fukao T; Shintaku H; Orii T; Tomatsu S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1795-1803. PubMed ID: 28673849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation.
    Li P; Thompson JN; Hug G; Huffman P; Chuck G
    Am J Med Genet; 1996 Sep; 64(4):531-5. PubMed ID: 8870917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome.
    Galán-Gómez E; Guerrero-Rico A; Cáceres-Marzal C; Zambrano-Castaño M; Moreno-Tejero ML; Grande-Tejada AM; Fernández-Hernández S; Vaquerizo-Madrid J; Cardesa-García JJ
    Eur J Med Genet; 2008; 51(3):268-71. PubMed ID: 18396123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.